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Patients who experience acute ischemic stroke may develop hyper-
glycemia, even in the absence of diabetes, but the exact mechanisms
are still unclear. Adipose tissue secretes numerous proinflammatory
cytokines and is involved in the regulation of glucose metabolism.
This study aimed to determine the effects of acute stroke on adipose
inflammatory cytokine expression. In addition, because sympathetic
activity is activated after acute stroke and catecholamines can regulate
the expression of several adipocytokines, this study also evaluated
whether alterations in adipose proinflammatory cytokines following
acute stroke, if any, were medicated by sympathetic system. Acute
ischemic brain injury was induced by ligating the right middle
cerebral artery and bilateral common carotid arteries in male adult
Sprague-Dawley rats. Adipose tumor necrosis factor- (TNF-) and
monocyte chemoattractant protein-1 (MCP-1) mRNA and protein
levels were determined by RT-PCR and enzyme-linked immunoassay,
respectively. The stroke rats developed glucose intolerance on days 1
and 2 after cerebral ischemic injury. The fasting blood insulin levels
and insulin resistance index measured by homeostasis model assess-
ment were higher in the stroke rats compared with the sham group.
Epididymal adipose TNF- and MCP-1 mRNA and protein levels
were elevated one- to twofold, in association with increased macro-
phage infiltration into the adipose tissue. When the rats were treated
with a nonselective -adrenergic receptor blocker, propranolol, before
induction of cerebral ischemic injury, the acute stroke-induced in-
crease in TNF- and MCP-1 was blocked, and fasting blood insulin
concentration and homeostasis model assessment-insulin resistance
were decreased. These results suggest a potential role of adipose
proinflammatory cytokines induced by the sympathetic nervous sys-
tem in the pathogenesis of glucose metabolic disorder in rats with
acute ischemic stroke.
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A HIGH PROPORTION OF PATIENTS suffering an acute stress, such as
stroke, may develop hyperglycemia, even in the absence of a
preexisting diagnosis of diabetes (7, 20, 32). Both human and
animal studies have suggested that stress-induced hyperglyce-
mia is not a benign occurrence and is associated with a high
risk of mortality after acute stroke (7, 20, 32). Some studies
have reported that decreased glucose can reduce ischemic brain
damage (5, 24). In view of the importance of blood glucose on
the prognosis of acute stroke, further elucidation of the patho-
genetic mechanisms of poststroke hyperglycemia, whether due
to transiently acute stress or a worsening of previously undi-
agnosed diabetes, is warranted. Over the last decade, adipose
tissue has been found to secrete a number of cytokines, such as
tumor necrosis factor- (TNF-) and interleukin-6 (IL-6),
chemokines, such as monocyte chemoattractant protein-1
(MCP-1), and adipokines, such as leptin and adiponectin,
involved in glucose metabolism, and the etiopathogenesis of
obesity-related insulin resistance (4, 12, 21). It has been shown
that subjects with obesity-related insulin resistance have a
higher local expression of TNF- in the adipose tissue (25).
Furthermore, TNF- can stimulate the production of other
cytokines and chemokines, such as IL-6 and MCP-1, and in
concert with them induce insulin resistance (14, 35). However,
whether these adipose tissue-derived bioactive substances con-
tribute to the development of hyperglycemia in acute stroke is
less studied. To examine the relationship between adipocyto-
kines and poststroke hyperglycemia, we used a rat model with
ischemic brain injury and examined the changes of several
adipose tissue-derived cytokines, including TNF-, IL-1,
IL-6, MCP-1, leptin, and adiponectin, after acute stroke. In
addition, sympathetic tone has been shown to be activated by
experimental cerebral ischemia (10, 34), and several studies
have reported that sympathetic nervous system regulates the
expression of several adipocytokines through adipocyte -ad-
renergic receptors (3, 19, 26). Therefore, this study also deter-
mined whether alterations in adipose proinflammatory cyto-
kines following acute stroke, if any, were medicated by sym-
pathetic system using a nonselective -adrenergic receptor
blocker, propranolol.
MATERIALS AND METHODS
Animals and induction of cerebral ischemia. Adult male Sprague-
Dawley rats (300–350 g) were anesthetized with phenobarbital (60
mg/kg body wt, intramuscular). The body temperature of each rat was
maintained at 37.0  0.5°C using a heating pad. Focal ischemic
infarcts in the right lateral cerebral cortex were produced by ligating
right middle cerebral artery (MCA) and bilateral common carotid
arteries (CCAs), as described previously with some modifications (8,
9, 29). For ligation of right MCA, the animal was placed in a lateral
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position, and a skin incision was made at the midpoint between the
right lateral canthus and the anterior pinna. The temporal muscle was
retracted, and a small (3 mm in diameter) craniectomy was made at
the junction of the zygoma and squamosal bone using a drill cooled
with saline solution. The dura was opened with fine forceps guided by
a dissecting microscope to expose the right MCA. During the whole
operative procedure, care was taken to avoid physical and thermal
injury to the cortex. For ligation of CCAs, both the CCAs were
exposed by midline anterior cervical incision. Both CCAs and the
right MCA were ligated with a square knot using 10–0 suture. For
sham operations, the animals underwent similar surgical procedure
with isolation of both CCA and right MCA, and a needle was passed
beneath the artery but without ligation.
Quantification of ischemic infarction. The brains were quickly
removed 1, 2, 3, or 7 days after surgery and chilled in cold PBS for
5 min. Coronal sections (2-mm thick) were cut using a tissue slicer.
Sections were immersed in PBS containing 2% triphenyltertrazolium
chloride at 37°C for 30 min and then fixed in 10% phosphate-buffered
formalin for 45 min (8). The triphenyltertrazolium chloride is reduced
by certain enzymes in normal tissues to a deep red, fat-soluble,
light-sensitive compound, clearly delineating ischemic areas. The
areas of infarction were measured using a computer image analysis
system (Alpha Innotech, IS1000).
Determination of glucose tolerance and insulin resistance. Insulin
resistance was determined in fasting rats before and 1, 2, 3, and 7 days
after inducing ischemic brain injury. Blood was sampled for glucose
analysis before glucose loading and 30, 60, and 120 min after
injecting glucose solution (2 g/kg, intraperitoneal). The total area
under curve for glucose during intraperitoneal glucose tolerance test
(2-h glucose area under curve) was calculated using the trapezoidal
(trapezium) rule. Insulin resistance was evaluated according to the
homeostasis model assessment (HOMA), described by Matthews et
al. (31). The HOMA insulin resistance (HOMA-IR) index is calcu-
lated as [fasting insulin (IU/ml)  fasting glycemia (mol/l)]/22.5.
Blood glucose was measured from a tail vein using a hand-held
Accucheck glucometer (Roche Diagnostics, Indianapolis, IN), and
fasting blood insulin levels were measured in blood samples collected
before intraperitoneal glucose injection using a rat/mouse ELISA
(Linco Research, St. Charles, MO), according to the manufacturer’s
instructions.
Blood and adipose tissue preparation. On days 1, 2, 3, and 7 after
ischemic brain injury, the experimental and sham-operated rats were
anesthetized with intraperitoneal sodium phenobarbital and intra-
arterial catheterization of the left femoral artery for blood sampling.
Blood was immediately subjected to centrifugation, and plasma sam-
ples were stored at 70°C until analysis. In addition, the epididymal
adipose tissue was rapidly dissected, weighed, and stored in liquid
nitrogen until analysis.
Administration of propranolol. In some experiments, propranolol
(2 mg/kg) was injected intraperitoneally 3 h before the induction of
cerebral ischemia. Thereafter, the blood and adipose tissues were
collected as described above.
Cytokine analyses in blood and adipose tissue. The epididymal fat
was thoroughly homogenized in tissue protein extraction reagents
(T-PER, Pierce Biotechnology), and the supernatant fluids obtained
with centrifugation at 10,000 rpm for 10 min were collected. The
adipose tissue and blood samples were assayed for TNF-, IL-1,
IL-6, MCP-1, leptin, and adiponectin using the rat inflammation kit
(BD Bioscience).
RNA preparation and gene expression analysis. Total mRNA was
extracted from frozen epididymal fat tissue samples using TriZol agents
(Life Technologies), and the mRNA concentrations were determined by
UV light absorbance at 260 nm. The expression of adipose proinflam-
matory cytokine mRNA was determined by semiquantitative RT-PCR
analysis normalized to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). Briefly, 1–5 g of total RNA were transcribed using reverse
transcriptase, and poly(dT)12–18 primer, and then PCR reaction was
conducted in a DNA Thermal Cycler 480 (Perkin-Elmer, Norwalk, CT).
The primer sets used in this study were as follows: forward 5=-
CCCTCACACTCAGATCATCTTCTCAA and reverse 5=-TCTAAG-
TACTTGGGCAGGTTGACCTC for TNF-; forward 5=-TGCAG-
GTCTCTGTCACGCTTC and reverse 5=-TTCTCCAGCCGACTCAT-
TGG for MCP-1; forward 5=-ACCACAGTCCATGCCATCAC and
reverse 5=-TCCACCACCCTGTTGCTGTA for GAPDH. The target
gene and GAPDH bands were measured by densitometry using Image
Quant Analysis Software.
Western blot analyses. Adipose protein samples (100 g protein)
were subjected to electrophoresis and immunoblotted with an anti-
body to hormone-sensitive lipase diluted 1:1,000 (Cayman Chemical,
Ann Arbor, MI). Then blotted membranes were stained with anti-
rabbit or anti-goat IgG secondary antibodies labeled with horseradish
peroxidase (Amersham, Arlington Heights, IL). Specific protein bands
were visualized by enhanced chemiluminescence (Amersham). All
measured protein levels were quantified by densitometry, and the
percent change relative to sham-operated rats was determined after
normalization by GAPDH, determined with anti-GAPDH antibody
diluted 1:3,000 (Santa Cruz Biotech, Santa Cruz, CA).
Histology and immunohistochemistry. Excised adipose specimens
were fixed in 10% formalin and embedded with paraffin for hema-
toxylin and eosin staining, and the average cell size of 100 adipocytes
was measured in six continuous sections. For immunohistochemical
examination, sections of formalin-fixed, paraffin-embedded epididy-
mal adipose tissue were deparaffinized and incubated with anti-CD68
antibody. Then sections were washed three times in TBS-Tween 20
(20 mmol/l Tris, 137 mmol/l NaCl, 0.05% Tween 20, pH 7.5) and
incubated with a biotinylated secondary antibody, followed by an
avidin-biotin-peroxidase complex. The immunoreactive signal was
developed by color deposition using diaminobenzidine as substrate.
The average number of CD68-positive immunoactivity per observa-
tion was counted in six continuous sections.
Statistical analysis. All data were expressed as means  SE.
Differences were determined by the Student’s unpaired t-test. Com-
parisons among several groups were compared statistically by
ANOVA, followed by the Bonferroni multiple-comparisons test. The
correlation between two variables was analyzed by Spearman’s rank-
order correlation. Results were considered significant at P 0.05. All
data were analyzed using SPSS software (Statistical Package for the
Social Sciences, version 6.0 for Windows, SPSS, Chicago, IL).
RESULTS
Changes in glucose tolerance following acute cerebral
ischemia. The body weight of the rats was significantly decreased
1, 2, and 3 days after the induction of cerebral ischemia compared
with before surgery, and regained on day 7 (Table 1). The
epididymal fat weight was also decreased significantly during the
course of ischemic stroke. The infarct brain volume was
enlarged maximally in the first 2 days after artery ligation and
thereafter diminished progressively. The rats with acute cere-
bral ischemia had higher insulin and HOMA-IR levels on days
1, 2, and 3 after surgery compared with the sham-operated rats
(Table 1). In addition, the stroke rats had higher postload
glucose levels at 30, 60, 90, and 120 min after the intraperitoneal
glucose injection compared with control rats during in the first 2
days following induction of acute ischemic stroke (Fig. 1). Al-
though fasting blood glucose values in stroke rats were similar
to that in the control group (Table 1), a moderate positive
correlation was observed between infarct brain volume and
fasting blood glucose levels (r  0.55, P  0.05).
Blood and adipose proinflammatory cytokine expression. To
determine adipose proinflammatory cytokine expression fol-
lowing acute ischemic stroke, we quantified the levels of
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MCP-1, TNF-, IL-1, and IL-6 in the epididymal adipose
tissue, as well as the adipocytokines, including leptin and
adiponectin. The TNF- and MCP-1 mRNA and protein levels
were significantly increased in the epididymal adipose tissue
from the stroke rats on the first 3 days following surgery, with
adipose TNF- level peaked on day 1 and MCP-1 on day 2
(Fig. 2, A and B), respectively, although circulating TNF- and
MCP-1 concentrations were not changed (data not shown). In
addition, adipose and circulating leptin levels were signifi-
cantly increased 1 day after the ischemic stroke, but progres-
sively declined thereafter (Fig. 2C). However, adipose IL-6,
IL-1, and adiponectin were not differentially expressed be-
tween the two groups (data not shown). A significant positive
correlation was observed between adipose TNF- and
HOMA-IR (r  0.91, P  0.01) and adipose TNF- and
insulin (r  0.93, P  0.01).
Macrophage infiltration and hormone-sensitive lipase ex-
pression of adipose tissue. Hematoxylin and eosin staining of
epididymal adipose tissue sections showed that the number of
hematoxylin-positive nuclei was increased in acute stroke rats
compared with sham-operated rats after induction of cerebral
ischemia (Fig. 3A). The proportion of adipocyte size in the 25-
to 50-m range from epididymal adipose in stroke rats was
significantly higher compared with that in sham-operated rats
(P  0.05). Immune staining with an antibody against CD68,
a macrophage-specific cell surface glycoprotein, showed that
anti-CD68-positive macrophages were significantly elevated in
the epididymal adipose tissue of rats with cerebral ischemia
(Fig. 3B). The hormone-sensitive lipase protein levels were
significantly elevated in the epididymal fat of stroke rats on the
first 3 days following surgery, suggesting an enhanced lipolytic
process in the adipose tissue of rats with cerebral ischemia
(Fig. 4).
Propranolol effect on changes in proinflammatory cytokines,
glucose tolerance, and brain infarct volume. To look after a
potential role of the sympathetic nervous system in the in-
creased TNF- and MCP-1 expression in the adipose tissue
following cerebral ischemic stroke, we administrated propran-
olol before the induction of cerebral ischemia and showed that
stroke-induced increase in TNF- and MCP-1 24 h after
cerebral ischemia was almost blocked (Fig. 5, A and B, respec-
tively), but without an effect on the infarct volume (data not
shown). In addition, the fasting insulin concentrations and
HOMA-IR were also diminished in stroke rats that received
Table 1. Serial change of metabolic characteristics in sham-operated and cerebral ischemia rats
Baseline Day 1 Day 2 Day 3 Day 7
n 6–8 6–8 6–8 6–8 6–8
Body weight, g
Sham 317.8  3.8 304.2  3.9 309.4  3.6 315.7  3.5 328.3  3.7
Ischemia 318.3 3.8 289.2  5.9* 290.0  6.9* 266.0  12.2*† 309.6  13.8*
Epididymal fat, g
Sham 3.2  0.2 3.2  0.1 3.2  0.3 3.2  0.5 3.3  0.3
Ischemia 3.2 0.2 2.5  0.4* 2.2  0.2*† 2.0  0.3*† 2.4  0.3*
Infarct volume, %
Sham
Ischemia 28.0 3.4 36.3  3.9† 22.7  2.6† 8.3  1.3†
Fasting glucose, mM
Sham 6.1  0.4 6.1  0.4 6.1  0.4 6.1  0.4 6.1  0.4
Ischemia 6.1 0.3 5.6  0.3 6.1  0.6 5.7  0.2 5.7  0.1
Fasting insulin, IU/ml
Sham 7.7  0.2 7.7  0.2 7.7  0.2 7.7  0.2 7.7  0.2
Ischemia 7.7 0.3 15.3  3.8* 10.5  1.2*† 9.9  0.7*† 8.9  0.3†
HOMA-IR
Sham 2.1  0.2 2.1  0.2 2.1  0.2 2.1  0.2 2.1  0.2
Ischemia 2.1 0.3 3.7  0.7* 2.8  0.3*† 2.5  0.1*† 2.2  0.1†
Values are means  SE; n, no. of rats. HOMA-IR, homeostasis model assessment-insulin resistance. *P  0.05 vs. sham, unpaired Student’s test. †P  0.05
vs. ischemia day 1, one-way ANOVA and Bonferroni’s test.
Fig. 1. Blood glucose concentrations (A) and areas under the curve (AUC; B)
during intraperitoneal glucose tolerance test in sham-operated and cerebral
ischemia rats on days 1, 2, 3, and 7 after surgery (n  6–8 for each
experiment). Values are means  SE. *P  0.05 vs. sham, unpaired Student’s
test. **P  0.05 vs. ischemia day 1, one-way ANOVA and Bonferroni’s test.
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propranolol (Fig. 6, A and B, respectively). To evaluate the role
of another stress hormone, glucocorticoid, in poststroke hyper-
glycemia, we measured the circulating cortisol concentrations
after inducing cerebral ischemia and found that blood cortisol
values did not significantly differ between the stroke and
control rats (data not shown).
DISCUSSION
Many factors, including counterregulatory hormones, aging,
and bed rest have been proposed to be involved in development
of stress illness-related hyperglycemia (6, 27, 33, 37). The
present study was aimed to examine whether other possible
mediators, such as adipose proinflammatory cytokines, might
also participate in the acute stress hyperglycemic reaction.
Using an ischemic stroke rat model, we found that blood
insulin, HOMA-IR levels, and postload glucose levels after
intraperitoneal glucose injection were significantly elevated
during the first 2 days following acute cerebral ischemia, and
there was a positive relationship between fasting blood glucose
and infarct brain volumes. Clinical studies have reported that
hyperglycemia is prevalent in 20–50% of patients with acute
ischemic stroke, even without a disease history of diabetes
mellitus, and associated with stroke infarct volumes measured
on cerebral computed tomography (7, 20, 32). Furthermore,
Fig. 2. Expression of adipocytokines in epididymal adipose tissue of sham-operated and cerebral ischemia rats on days 1, 2, 3, and 7 after surgery (n  6–8
for each experiment). A: relative changes of adipose TNF- protein and mRNA levels. B: relative changes of adipose monocyte chemoattractant protein-1
(MCP-1) protein and mRNA levels. C: relative changes of adipose and serum leptin levels. *P 0.05 vs. sham, unpaired Student’s test. **P 0.05 vs. ischemia
day 1, one-way ANOVA and Bonferroni’s test.
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among the patients with poststroke hyperglycemia, about one-
third of them manifest only postload hyperglycemia with
normal fasting blood glucose (11). In our acute stroke rat
model, the blood glucose profiles and the relationship between
glucose and infarct brain volume during the initial 2 days after
cerebral ischemia appeared to resemble those observed in acute
stroke patients. Although the postload glucose levels in stroke
rats returned to the sham values on day 3 after cerebral
ischemia, the stroke rats still showed somewhat insulin resis-
tance with elevated circulating insulin and HOMA-IR values.
Of the cytokines/chemokines/adipokines measured, it was
found that expression of TNF- and MCP-1 mRNA and
protein was increased in the adipose tissue of acute stroke rats
concomitantly with macrophage infiltration into the adipose
tissue and correlated with HOMA-IR and insulin levels. These
data, all together, suggested a potential relationship between
increased adipose proinflammatory cytokines and poststroke
hyperglycemia and insulin resistance.
A large accumulation of data has documented the important
role of adipose TNF- in the development of insulin resistance in
obesity and diabetes (4, 12, 21). Notably, some experimental
studies propose that TNF- can also be increasingly produced by
adipose tissue during critical illness (2, 13, 17) and, consequently,
participates in the development of insulin resistance in stress
illnesses (39–41). Our study findings seemed to support that
rationale. Although this study did not determine whether the
increased adipose TNF- expression was due to infiltrated mac-
rophages or the adipocytes in the stroke rats, this increased
adipose cytokine expression, regardless of its exact sources,
would be expected to act locally in the adipose tissue and, in
consequence, produce a variety of metabolic abnormalities, such
as poststroke insulin resistance and hyperglycemia. However, it
should be noted that, in the stroke rats, the time pattern of adipose
TNF- and glucose changes did not match each other exactly at
the same rate, suggesting that increased adipose TNF-might just
represent an epiphenomenon of the mechanisms underlying
stroke-related insulin resistance, and further studies are necessary
to elucidate a more precise role for TNF- in metabolic alterations
in acute stroke. In addition to participating in pathogenesis of
insulin resistance, TNF- is reported to be involved in fat mass
loss in some wasting diseases, such as human immunodeficiency
virus infection-associated lipodystrophy (22). It has been shown
that TNF- can downregulate several genes involved in adipo-
genesis, or stimulate lipolysis, and thus induce lipoatrophy (18). In
the acute stroke rats, the epididymal fat mass was at the lowest
level on day 3 after acute cerebral ischemia, which was preceded
by increased expression of adipose TNF- and hormone-sensitive
lipase. On day 7, when adipose TNF- level returned to the sham
value, the stroke rats began to regain the initial fat mass loss.
These findings were in agreement with the potential role of
TNF- in the regulation of adipose mass.
MCP-1 has been suggested to be another novel adipocyto-
kine related to the development of insulin resistance, and its
levels in the adipose tissue and plasma are highly elevated in
obesity (15, 35). In addition to the known in vitro effects
impairing insulin signaling, MCP-1 can attract and activate
circulating monocytes into the adipose tissue and turn them
into macrophages, resulting in adipose inflammation and in-
ducing insulin resistance in adipocytes (15, 35, 43, 44). In the
acute stroke rats, the adipose MCP-1 expression was increased
since day 1 after induction of cerebral ischemia, likely con-
tributing to subsequent adipose macrophage infiltration. Based
on the physiological effects of MCP-1, it was supposed that
increased MCP-1 expression and macrophage infiltration
Fig. 2—Continued
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within the adipose tissue might also participate in the occur-
rence of poststroke hyperglycemia and insulin resistance, or
even other pathological consequence, such as brain injury (39).
MCP-1 has also been shown to be upregulated by TNF- in
vitro in adipocytes, at both the gene expression and protein
secretion levels (35, 42). According to the time pattern of peak
adipose TNF- and MCP-1 expression in stroke rats, it was
speculated that TNF- might induce MCP-1 production, which
thus further reinforced the inflammatory state in the adipose
tissue after acute cerebral ischemia.
Leptin, a hormone secreted by adipose tissue in direct propor-
tion to the amount of body fat, has main functions of reducing
food intake, promoting energy expenditure, and balancing body
weight through its effects in the central nervous system (28).
Moreover, recent animal experimental study showed that leptin
expression was also increased in ischemic brain parenchymal
tissue and proposed that leptin could provide neuroprotection and
inflammation modulation effects (36). Therefore, the early in-
creased adipose leptin expression 1 day after acute ischemic
stroke probably represented an adaptive response against the
poststroke inflammatory cascade. However, it should be noted
that the stroke rats on day 1 after surgery had a lower body fat
mass than sham-operated rats, implicating factors other than
adiposity itself that may be responsible for this leptin upregula-
tion. Administration of TNF- has been shown to stimulate leptin
production and secretion from adipose tissue (16). Given that
TNF- can induce leptin expression and secretion, and adipose
TNF- levels were increased after acute cerebral ischemia, it was
thought that an interaction between TNF- and leptin might exist
in the initial phase of acute stroke. On days 2 and 3 after induction
of ischemic stroke, adipose leptin expression was decreased con-
comitantly with loss of epididymal fat mass, despite increased
TNF-, suggesting that the stimulatory effect of TNF- on leptin
might be overridden by some other, as yet unidentified, factor(s).
In addition, this decreased leptin was thought to have an adverse
influence on poststroke glucose metabolism (23, 28).
Much experimental evidence has demonstrated that adipose
tissue is innervated by the sympathetic nervous system in rodents,
which can regulate lipolysis, fat cell number, proliferation, and the
secretion of some adipocytokines, such as TNF- and MCP-1 (3,
19, 26). Furthermore, the activity of the sympathetic nervous
system has been shown to be increased in obese individuals and
proposed to contribute to insulin resistance through the various
effects of catecholamines on adipocytes (38). Accordingly, be-
Fig. 3. Hematoxylin and eosin (A) and im-
munohistochemical staining using anti-
CD68 (top; B) of adipose samples in sham-
operated and cerebral ischemia rats obtained
on days 1, 2, and 3 after surgery (400).
Scale bar  50 m. B, bottom: data are
presented as the number of CD68-positive
cells per field (left y-axis for ischemia rats,
and right y-axis for sham rats). Values are
means  SE. *P  0.05 vs. sham, unpaired
Student’s test.
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cause acute cerebral ischemic infarction evoked an activation of
sympathetic tone, it was hypothesized that the increased adipose
TNF- and MCP-1 expression might be related to the activation
of the sympathetic nervous system. To test this hypothesis, the
present study demonstrated that the administration of a -adreno-
ceptor antagonist near completely suppressed the increase in
adipose TNF- and MCP-1, as well as the HOMA-IR and blood
insulin levels after ischemic stroke. This finding suggested a role
of sympathetic nervous system activation following acute stroke,
especially -adrenergic stimulation, in the upregulation of adipose
TNF- and MCP-1 production, and thus the development of
poststroke glucose metabolic disorder.
The present study had several limitations, and it is important to
interpret the laboratory findings cautiously. First, only a cerebral
ischemic model was used, and whether other stroke models, such
as intracranial hemorrhage (7, 20, 32), have similar results is not
known. Second, we did not directly address the exact causal
relationship between the adipose proinflammatory response and
hyperglycemia in the acute stroke rats. The increased adipose
TNF- and MCP-1 expression might be possible due to the
Fig. 3—Continued
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poststroke hyperglycemia itself rather than its causes (30). In
addition, this study only analyzed proinflammatory cytokine ex-
pression in the epididymal adipose. The sympathetic nervous
system drive to the white adipose tissue has been reported to not
be uniform across the different fat pads, although the systemic
leptin levels were increased in the stroke rats (3). Third, other
stress-related factors possibly contributed to the development of
insulin resistance in acute stroke. Lipolysis and free fatty acid
release have been shown to increase following acute stroke, and
both of them could affect the insulin sensitivity (1), although
circulating cortisol levels were not increased after induction of
cerebral ischemia in this study. Fourth, this study only used the
-adrenoreceptor antagonist at a single dose, and dose-dependent
effects were not investigated. In addition, the beneficial effects of
propranolol on blood glucose and adipose TNF- and MCP-1
were possible due to its protection of neurons from ischemic
injury, although this study did not show that -adrenergic block-
ers reduced the cerebral damage area on day 1 after surgery.
Additional experiments are necessary to address all of these
issues.
In summary, the present study demonstrated that the expres-
sion of TNF- and MCP-1 and macrophage infiltration was
increased in the adipose tissue of ischemic stroke rats, in
association with glucose intolerance. In contrast, the adminis-
tration of the -adrenergic antagonist nearly reversed the
poststroke inflammatory response in the adipose tissue, as well
as insulin resistance. These findings suggest a potential role of
the adipose proinflammatory cytokines induced by sympathetic
nervous system in the pathogenesis of glucose metabolic dis-
order following acute ischemic stroke.
Fig. 4. Expression of hormone-sensitive lipase protein in epididymal adipose
tissue of sham-operated and cerebral ischemia rats on days 1, 2, and 3 after
surgery (n  6–8 for each experiment). Values are means  SE. *P  0.05
vs. sham, unpaired Student’s test. **P  0.05 vs. ischemia day 1, one-way
ANOVA and Bonferroni’s test.
Fig. 5. Effects of administration of propranolol at 3 h before induction of
cerebral ischemia on epididymal TNF- (A) and MCP-1 protein levels (B) in
sham-operated and cerebral ischemia rats on day 1 after surgery (n  6–8 for
each experiment). Values are means  SE. S, sham; S	I, sham with propran-
olol; I, ischemia without propranolol; I	P, ischemia with propranolol. *P 
0.05 vs. sham. **P  0.05 vs. ischemia without propranolol.
Fig. 6. Effects of administration of propranolol at 3 h before induction of
cerebral ischemia on blood insulin (A) and homeostasis model assessment-
insulin resistance (HOMA-IR) levels (B) in sham-operated and cerebral ische-
mia rats on day 1 after surgery (n  6–8 for each experiment). Values are
means  SE. *P  0.05 vs. sham. **P  0.05 vs. ischemia without
propranolol.
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